Literature DB >> 8391253

Platelet-activating factor: receptors and signal transduction.

W Chao1, M S Olson.   

Abstract

During the past two decades, studies describing the chemistry and biology of PAF have been extensive. This potent phosphoacylglycerol exhibits a wide variety of physiological and pathophysiological effects in various cells and tissues. PAF acts, through specific receptors and a variety of signal transduction systems, to elicit diverse biochemical responses. Several important future directions can be enumerated for the characterization of PAF receptors and their attendant signalling mechanisms. The recent cloning and sequence analysis of the gene for the PAF receptor will allow a number of important experimental approaches for characterizing the structure and analysing the function of the various domains of the receptor. Using molecular genetic and immunological technologies, questions relating to whether there is receptor heterogeneity, the precise mechanism(s) for the regulation of the PAF receptor, and the molecular details of the signalling mechanisms in which the PAF receptor is involved can be explored. Another area of major significance is the examination of the relationship between the signalling response(s) evoked by PAF binding to its receptor and signalling mechanisms activated by a myriad of other mediators, cytokines and growth factors. A very exciting recent development in which PAF receptors undoubtedly play a role is in the regulation of the function of various cellular adhesion molecules. Finally, there remain many incompletely characterized physiological and pathophysiological situations in which PAF and its receptor play a crucial signalling role. Our laboratory has been active in the elucidation of several tissue responses in which PAF exhibits major autocoid signalling responses, e.g. hepatic injury and inflammation, acute and chronic pancreatitis, and cerebral stimulation and/or trauma. As new experimental strategies are developed for characterizing the fine structure of the molecular mechanisms involved in tissue injury and inflammation, the essential role of PAF as a primary signalling molecule will be affirmed. Doubtless the next 20 years of experimental activity will be even more interesting and productive than the past two decades.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8391253      PMCID: PMC1134157          DOI: 10.1042/bj2920617

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  176 in total

1.  Platelet-activating factor induces phospholipid turnover, calcium flux, arachidonic acid liberation, eicosanoid generation, and oncogene expression in a human B cell line.

Authors:  P G Schulam; A Kuruvilla; G Putcha; L Mangus; J Franklin-Johnson; W T Shearer
Journal:  J Immunol       Date:  1991-03-01       Impact factor: 5.422

2.  Identification of receptors for platelet-activating factor in rat Kupffer cells.

Authors:  W Chao; H Liu; M DeBuysere; D J Hanahan; M S Olson
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

3.  Stimulation of human neutrophil degranulation with 1-O-octadecyl-2-O-acetyl-SN-glyceryl-3-phosphorylcholine: modulation by inhibitors of arachidonic acid metabolism.

Authors:  R J Smith; B J Bowman
Journal:  Biochem Biophys Res Commun       Date:  1982-02-26       Impact factor: 3.575

4.  Receptor-effector coupling in platelets: roles of guanine nucleotides.

Authors:  R J Haslam; K A Williams; M M Davidson
Journal:  Adv Exp Med Biol       Date:  1985       Impact factor: 2.622

5.  Phorbol 12-myristate 13-acetate inhibits binding of leukotriene B4 and platelet-activating factor and the responses they induce in neutrophils: site of action.

Authors:  M Yamazaki; J Gomez-Cambronero; M Durstin; T F Molski; E L Becker; R I Sha'afi
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Release of arachidonic acid from 1-alkyl-2-acyl-sn-glycero-3-phosphocholine, a precursor of platelet-activating factor, in rat alveolar macrophages.

Authors:  D H Albert; F Snyder
Journal:  Biochim Biophys Acta       Date:  1984-10-24

7.  The effect of acetylglyceryl ether phosphorylcholine on glycogenolysis and phosphatidylinositol 4,5-bisphosphate metabolism in rat hepatocytes.

Authors:  R A Fisher; S D Shukla; M S Debuysere; D J Hanahan; M S Olson
Journal:  J Biol Chem       Date:  1984-07-25       Impact factor: 5.157

8.  Platelet-activating factor mobilizes intracellular calcium in vascular smooth muscle cells.

Authors:  V M Doyle; J A Creba; U T Rüegg
Journal:  FEBS Lett       Date:  1986-03-03       Impact factor: 4.124

9.  Interactions in platelets between G proteins and the agonists that stimulate phospholipase C and inhibit adenylyl cyclase.

Authors:  L F Brass; M J Woolkalis; D R Manning
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

10.  Biosynthesis of platelet-activating factor (PAF-acether). V. Enhancement of acetyltransferase activity in murine peritoneal cells by calcium ionophore A23187.

Authors:  E Ninio; J M Mencia-Huerta; J Benveniste
Journal:  Biochim Biophys Acta       Date:  1983-05-16
View more
  100 in total

Review 1.  Lipid acetylation reactions and the metabolism of platelet-activating factor.

Authors:  R R Baker
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

Review 2.  Membrane phospholipid alterations in Alzheimer's disease: deficiency of ethanolamine plasmalogens.

Authors:  A A Farooqui; S I Rapoport; L A Horrocks
Journal:  Neurochem Res       Date:  1997-04       Impact factor: 3.996

3.  Increased hepatic platelet activating factor (PAF) and PAF receptors in carbon tetrachloride induced liver cirrhosis.

Authors:  Y Yang; E M Nemoto; S A K Harvey; V M Subbotin; C R Gandhi
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

4.  Human neutrophils specifically interact with human monocyte-derived macrophage monolayers.

Authors:  M Magnarin; P Spessotto; M R Soranzo; A Pontillo; G Zabucchi
Journal:  Inflammation       Date:  2000-02       Impact factor: 4.092

5.  Cytokines and neutrophils as important mediators of platelet-activating factor-induced kinin B1 receptor expression.

Authors:  Elizabeth S Fernandes; Giselle F Passos; Maria M Campos; Glória E P de Souza; Juliana F Fittipaldi; Jorge L Pesquero; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2005-09       Impact factor: 8.739

6.  Independent regulation of periarteriolar and perivenular nitric oxide mechanisms in the in vivo hamster cheek pouch microvasculature.

Authors:  David D Kim; Takehito Kanetaka; Ricardo G Durán; Fabiola A Sánhez; H Glenn Bohlen; Walter N Durá
Journal:  Microcirculation       Date:  2009-02-23       Impact factor: 2.628

7.  Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat paw.

Authors:  Elizabeth S Fernandes; Giselle F Passos; Maria M Campos; José G V C Araújo; Jorge L Pesquero; Maria C Avelllar; Mauro M Teixeira; João B Calixto
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  Flow cytometric assay of phagocytic activity of human neutrophils and monocytes in whole blood by neutral red uptake.

Authors:  P Antal; S Sipka; P Surányi; I Csipo; T Seres; L Maródi; G Szegedi
Journal:  Ann Hematol       Date:  1995-05       Impact factor: 3.673

9.  Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats.

Authors:  J A Rivera; J Werner; A L Warshaw; K B Lewandrowski; D W Rattner; C Fernández del Castillo
Journal:  Int J Pancreatol       Date:  1998-04

10.  Synthesis of platelet-activating factor and its receptor expression in Kupffer cells in rat carbon tetrachloride-induced cirrhosis.

Authors:  Yin-Ying Lu; Chun-Ping Wang; Lin Zhou; Yan Chen; Shu-Hui Su; Yong-Yi Feng; Yong-Ping Yang
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.